Literature DB >> 34862215

Diagnosis and management of non-cystic fibrosis bronchiectasis.

Laura Macfarlane1, Kartik Kumar2, Thomas Scoones3, Andrew Jones4, Michael R Loebinger5, Robert Lord4.   

Abstract

Bronchiectasis is a heterogeneous and increasingly prevalent chronic pulmonary disease that is associated with significant morbidity. In this review, we outline how patients with bronchiectasis may present clinically and describe an approach to its diagnosis, including how to identify an underlying aetiology. We discuss the important considerations when treating either acute exacerbations or stable disease and provide an overview of the role of long-term antimicrobials, airway clearance methods and other supportive management. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  Pseudomonas aeruginosa; airway clearance; bronchiectasis; macrolides; non-tuberculous mycobacteria

Mesh:

Substances:

Year:  2021        PMID: 34862215      PMCID: PMC8806287          DOI: 10.7861/clinmed.2021-0651

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  20 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

Review 2.  Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Authors:  Patrick A Flume; James D Chalmers; Kenneth N Olivier
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

Review 3.  Bronchial artery embolization in hemoptysis: a systematic review.

Authors:  Ananya Panda; Ashu Seith Bhalla; Ankur Goyal
Journal:  Diagn Interv Radiol       Date:  2017 Jul-Aug       Impact factor: 2.630

4.  Outpatient Parenteral Antimicrobial Treatment for Non-Cystic Fibrosis Bronchiectasis Exacerbations: A Prospective Multicentre Observational Cohort Study.

Authors:  Luis Eduardo López-Cortés; Rut Ayerbe-García; Laura Carrasco-Hernández; Elena Fraile-Ramos; Juan Manuel Carmona-Caballero; Esther Quintana-Gallego; Agustín Valido-Morales; Julia Praena; Jerónimo Pachón-Diaz
Journal:  Respiration       Date:  2019-07-09       Impact factor: 3.580

5.  Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.

Authors:  James D Chalmers; Wim Boersma; Mike Lonergan; Lata Jayaram; Megan L Crichton; Noel Karalus; Steven L Taylor; Megan L Martin; Lucy D Burr; Conroy Wong; Josje Altenburg
Journal:  Lancet Respir Med       Date:  2019-08-09       Impact factor: 30.700

Review 6.  The clinical spectrum of pulmonary aspergillosis.

Authors:  Chris Kosmidis; David W Denning
Journal:  Thorax       Date:  2014-10-29       Impact factor: 9.139

7.  Non-tuberculous mycobacteria in patients with bronchiectasis.

Authors:  M Wickremasinghe; L J Ozerovitch; G Davies; T Wodehouse; M V Chadwick; S Abdallah; P Shah; R Wilson
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

8.  British Thoracic Society Guideline for bronchiectasis in adults.

Authors:  Adam T Hill; Anita L Sullivan; James D Chalmers; Anthony De Soyza; Stuart J Elborn; Andres R Floto; Lizzie Grillo; Kevin Gruffydd-Jones; Alex Harvey; Charles S Haworth; Edwin Hiscocks; John R Hurst; Christopher Johnson; Peter W Kelleher; Pallavi Bedi; Karen Payne; Hashem Saleh; Nicholas J Screaton; Maeve Smith; Michael Tunney; Deborah Whitters; Robert Wilson; Michael R Loebinger
Journal:  Thorax       Date:  2019-01       Impact factor: 9.139

Review 9.  Bronchiectasis and Aspergillus: How are they linked?

Authors:  Anthony De Soyza; Stefano Aliberti
Journal:  Med Mycol       Date:  2016-10-28       Impact factor: 4.076

10.  Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study.

Authors:  Jennifer K Quint; Elizabeth R C Millett; Miland Joshi; Vidya Navaratnam; Sara L Thomas; John R Hurst; Liam Smeeth; Jeremy S Brown
Journal:  Eur Respir J       Date:  2015-11-05       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.